|
|
高位结肠透析结合中药保留灌肠对慢性肾衰合并便秘患者肠道菌群的影响
|
Abstract:
目的：观察高位结肠透析结合中药保留灌肠治疗慢性肾衰合并便秘患者的临床疗效。方法：选取2021年2月至2022年8月于武汉市中医医院就诊的60例CKD 3~4期合并便秘的患者，采用随机数字表法分为对照组、观察组各30例，对照组予以西医对症及中药保留灌肠治疗，观察组在对照组的基础上加用高位结肠透析治疗，观察两组临床疗效。结果：两组治疗后在降低Bun、Scr、CRP、内毒素、便秘评分等方面与治疗前比较均有统计学意义(P < 0.05)，两组治疗后在降低肠道内大肠杆菌和肠球菌、升高乳酸杆菌和双歧杆菌菌群数量方面与治疗前比较均有统计学意义(P < 0.05)，部分指标观察组优于对照组。结论：高位结肠透析结合中药保留灌肠能有效改善肾功能、降低炎症因子、调节肠道菌群变化、提高肠道屏障功能、延缓慢性肾衰的进展。
Objective: To observe the clinical efficacy of high colon dialysis combined with retention enema of traditional Chinese medicine in the treatment of patients with chronic renal failure (CRF) and constipation. Methods: From February 2021 to June 2022, 60 patients with constipation in phase 3~4 of CKD were selected from Wuhan Hospital of Traditional Chinese Medicine. Randomized number table method was used to divide them into control group and observation group, 30 cases in each group. The control group was treated with symptomatic Western medicine and traditional Chinese medicine retention enema, and the observation group was treated with high level colon dialysis on the basis of the control group, and the clinical efficacy of the two groups was observed. Results: After treatment, the Bun, Scr, CRP, endotoxin and constipation score in two groups were statistically significant compared with before treatment (P < 0.05), there were statistically significant differences in the reduction of intestinal Escherichia coli and Enterococcus flora, and increase of Lactobacillus and Bifidobacterium flora in two groups compared with before treatment (P < 0.05). Some indexes of the observation group were better than the control group. Conclusion: High colonic dialysis combined with traditional Chinese medicine retention enema can effectively improve renal function, reduce inflammatory factors, regulate intestinal flora, improve intestinal barrier function and delay the progression of chronic renal failure.
| [1] | 陈小燕, 杨敏生, 曹雯. 肾衰复元汤治疗慢性肾衰竭疗效观察[J]. 陕西中医, 2021, 42(10): 1397-1399. |
| [2] | 许苑, 林玮涛, 邹川. 慢性肾功能衰竭便秘发生率及其相关因素分析[J]. 广东医学, 2016, 37(8): 1202-1204. |
| [3] | 金世峰, 周建华, 刘焜剑, 等. 基于“脾肾相关”理论探析肠道菌群对老年功能性便秘的影响[J]. 吉林中医药, 2022, 42(12): 1473-1476. |
| [4] | 汪荣泉, 陈颢元. 老年人慢性便秘与心血管疾病的关联性[J]. 中国临床保健杂志, 2019, 22(1): 22-24. |
| [5] | Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International, 100, 201-228.
https://doi.org/10.22141/2307-1257.10.4.2021.247896 |
| [6] | Drossman, D.A., Corazziari, E., Delvaux, M., et al. (2010) Appendix B: Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. Revista de Gastroenterología de México, 75, 798-801. https://doi.org/10.1038/ajg.2010.73 |
| [7] | 韩雁鹏, 宋志超, 张丽芬. 基于“络病”理论的慢性肾脏病中医病机、治法探究[J]. 中医药临床杂志, 2022, 34(9): 1599-1603. |
| [8] | 邹卫, 肖晓芬, 王晓慧, 等. 89例2-5期非透析慢性肾脏病患者肠道菌群特点分析[J]. 临床肾脏病杂志, 2022, 22(9): 742-747. |
| [9] | 陈丽华, 张美玲, 钟鸿斌, 等. 慢性肾脏病与肠道菌群相关性研究进展概述[J]. 临床肾脏病杂志, 2021, 21(1): 74-78. |
| [10] | 王媛媛, 周华. 慢性肾脏病微炎症与肠道菌群的研究进展[J]. 中国实用内科杂志, 2022, 42(5): 423-426. |
| [11] | Salehi-abargouei, A., Ghiasvand, R. and Hariri, M. (2017) Prebiotics, Prosynbiotics and Synbiotics: Can They Reduce Plasma Oxidative Stress Parameters? A Systematic Review. Probiotics and Antimicrobial Proteins, 9, 1-11.
https://doi.org/10.1007/s12602-016-9248-4 |
| [12] | 罗科娜, 蔡珂丹, 罗群. 肠道菌群代谢产物短链脂肪酸在慢性肾脏病中的研究进展[J]. 中国微生态学杂志, 2020, 32(8): 983-987. |
| [13] | 徐蕾, 马晓燕. 基于“肠-肾轴”理论治疗慢性肾脏病研究进展[J]. 陕西中医药大学学报, 2022, 45(3): 114-119. |
| [14] | 梁立锋. 中医药治疗慢性肾衰竭研究近况[J]. 中医学, 2022, 11(1): 132-136. |
| [15] | 冯立, 彭博文. 高位结肠透析联合中药保留灌肠对慢性肾衰患者肾功能及炎症介质的影响[J]. 世界最新医学信息文摘, 2019, 19(28): 189, 192. |
| [16] | 严梦婷, 林钐, 王江梅, 等. 高位结肠透析联合中药保留灌肠治疗慢性肾脏病4-5期湿浊证的临床观察[J]. 时珍国医国药, 2022, 33(9): 2198-2201. |
